TGA Approval

VYVANSE lisdexamfetamine dimesilate 20 mg capsules bottle (284019)

ARTG ID

284019

ARTG Name

VYVANSE lisdexamfetamine dimesilate 20 mg capsules bottle

Sponsor

Takeda Pharmaceuticals Australia Pty Ltd

ARTG Date

November 22, 2017

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD.

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2013-CMI-02070-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2013-PI-02051-1

Ingredient Name

lisdexamfetamine dimesilate

Empowering clinical research with data-driven insights and AI-powered tools.

VYVANSE lisdexamfetamine dimesilate 20 mg capsules bottle (284019) - TGA 批准文号 | MedPath